Roberto Civitelli, MD
NPI 1194743872 · Endocrinology, Diabetes & Metabolism Physician · Saint Louis, MO
Enrolled with Medicare as Practitioner - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Roberto Civitelli, MD is a Endocrinology, Diabetes & Metabolism Physician provider in Saint Louis, MO (NPI 1194743872).
Provider details
- NPI number
- 1194743872
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 36936 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
813 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Dxa Bone Density Measurement of Hip, Pelvis, Spine77080 | 267 | $37 |
| Calculation of Trabecular Bone Score (tbs) Using Imaging Data With Interpretation and Report on Fracture Risk77089 | 244 | $38 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 148 | $122 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 59 | $14 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 39 | $87 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ibandronate Sodium | 103 | 26 |
| Alendronate Sodium | 63 | 14 |
| Abaloparatidebrand: Tymlos | 33 | — |
| Teriparatide | 20 | — |
| Teriparatidebrand: Forteo | 14 | — |
| Raloxifene Hcl | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$184 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-18
- Last updated
- 2025-04-17
- Certified
- 2020-04-10
Frequently asked questions
- What is Roberto Civitelli's NPI number?
- Roberto Civitelli's National Provider Identifier (NPI) is 1194743872, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Roberto Civitelli's specialty?
- Roberto Civitelli is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
- Where is Roberto Civitelli located?
- Roberto Civitelli's practice location on file with NPPES is 10 Barnes West Dr, Saint Louis, MO 63141-6287.
- What is Roberto Civitelli's phone number?
- The practice phone number listed in the NPPES registry for Roberto Civitelli is (314) 454-7775.
- Does Roberto Civitelli accept Medicare?
- Roberto Civitelli is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Roberto Civitelli's NPI active?
- Yes — Roberto Civitelli's NPI (1194743872) is active in the NPPES registry as of the last update on 2025-04-17.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.